Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    Joint Biological Tactical Detection System Market Survey

    By Global Biodefense StaffNovember 18, 2014
    Share
    Facebook LinkedIn Reddit Email

    JPEO CBD - Joint Program Executive Office for Chemical and Biological DefenseThe U.S. Army Contracting Command this week issued a new Request for Information (RFI) in support of Increment II of the Joint Biological Tactical Detection System (JBTDS) program.

    The JBTDS Increment II will be a lightweight, low-cost, battery operable system designed to rapidly detect and collect a sample of airborne biological warfare agents. The JBTDS will be employed to maintain situational awareness for biological surveillance, intelligence, and reconnaissance mission, and sensitive/tactical site exploitation.

    The market survey seeks to gather current and future potential biological technologies for three tactical applications:

    • Unmanned Aerial Vehicle (UAV) Biological Sensor Platform
    • Unmanned Ground Sensors (UGS) Biological Sensor Platform
    • Unattended Biological Sensor Platform

    Specifically sought are lightweight biological system or components that incorporate technologies for detection or collection of biological agents while minimizing human interface.

    The effort is overseen by the Joint Product Manager (JPM) for Biological Detection Systems (BD) as part of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).

    Performance requirements and further details are available via Solicitation Number: W911SR-15-D-RFI-0010. The response deadline is January 30, 2015.

    CBRN Equipment Chemical Detection Collective Protection JBTDS JPEO-CBRND RFI
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleIchor Awarded DARPA ADEPT: PROTECT Contract
    Next Article Army Awards 30M to MediVector for Ebola Drug

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy